[ad_1]
OIn a recent 10-year period, rising prices for multiple sclerosis medications have increased Medicare spending by more than 10 times, and Part D recipients have seen their spending seven times, according to a new study.
Specifically, spending on multiple sclerosis drugs per 1,000 health program beneficiaries increased from nearly $ 7,800 in 2006 to more than $ 79,400 in 2016. At the same time, patient spending per 1,000 beneficiaries increased from $ 372 to nearly $ 2,700 for multiple sclerosis patients. during this same period. And the annual cost of treating these patients has risen from about $ 18,600 to nearly $ 75,900 or 12.8% per year, according to JAMA Neurology's analysis.
Unlock this item by subscribing to STAT Plus and enjoy your first 30 days for free!
TO START
What is it?
STAT Plus is STAT's premium subscription service for in-depth coverage and analysis of biotechnology, the pharmaceutical industry, politics and life sciences.
Our award-winning team covers Wall Street news, political developments in Washington, early scientific breakthroughs and clinical trial results, as well as disruption of healthcare in Silicon Valley and beyond.
What is included?
- Daily report and analysis
- The most comprehensive coverage of the sector by a powerful team of journalists
- Subscriber-only newsletters
- Daily newsletters to inform you about the most important news of the day's industry
- Intelligence Briefings Online
- Frequent opportunities to interact with experienced journalists and industry experts
- Exclusive events in the industry
- Premium access to networking events for subscribers across the country
- The best reporters in the industry
- The most trusted and connected newsroom in the healthcare industry
- And much more
- Exclusive interviews with industry leaders, profiles and high-end tools, such as our CRISPR Trackr.
[ad_2]
Source link